Type 2 diabetes screening andcare in Mexico

Objective. To update the type 2 diabetes (T2D) preva-lence, and to estimate the cascades of screening and care for T2D in the Mexican adult population. Materials and methods. We used information from the National Health and Nutrition Survey 2023. We estimated the cascade of screening using the eligible population according to NOM-015-SSA2-2010 and the T2D care cascade using diagnosed cases. Results. The prevalence of T2D was 18.4% (12.4% diagnosed and 6.0% undiagnosed); 83% of the adult popu-lation without a T2D diagnosis had risk factors that made them eligible for blood screening; from them, 27.7% were screened in the past year (goal 33.3%). From T2D cases, 72.8% visited the doctor at least once in the last year, 92.8% were under pharmacological treatment, 77.9% used treat-ment regularly and 25.8% had glycemic control. Patients that completed the three steps of care (follow-up, treatment and regular treatment) achieved slightly better glycemic control (34.4%). Conclusion. Mexico faces important challenges to guarantee screening, care and control of T2D. We propose some actions to improve the detection and control of T2D based on the evidence generated through screening and care cascades.